Jaguar plans further scrutiny to detect potential illegal short selling
cemagraphics
- Jaguar Health (NASDAQ:JAGX) said it has identified slight trade imbalances that appear worthy of further scrutiny, as part of its efforts to identify possible illegal short selling.
- The company announced in February that it engaged Shareholder Intelligence Services, LLC (ShareIntel) to help uncover and address potential trading abnormalities.
- "This effort has identified slight trade imbalances that appear worthy of further scrutiny. We are committed to protecting the interests of our shareholders and maximizing shareholder value, and are continuing to engage ShareIntel to focus on this initiative," said Jaguar's President and CEO Lisa Conte.
- If effort leads to any findings which are material, the company will update the market, Conte added.
- JAGX +1.33% to $0.58 premarket April 6